Pull-out Tenolysis Versus Simple A1 Pulley Release in Trigger Digits
Launched by ELENI KARAGERGOU · Dec 19, 2024
Trial Information
Current as of November 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical approaches for treating trigger finger, a condition that causes painful catching or popping of the finger when you try to move it. The trial will compare a simple surgery called A1 pulley release with another method that involves pulling the tendons out to help free them from any scar tissue that may have formed. Researchers want to find out if this additional step, known as pull-out tenolysis, helps patients regain better movement, strength, and less pain compared to just the simple surgery.
To participate in this trial, individuals must be between the ages of 65 and 75 and have experienced a single trigger finger that hasn't improved with other treatments like injections or splinting. People with other joint issues or those who have had additional surgeries at the same time will not be eligible. Participants can expect to receive one of the two surgical treatments and will be monitored to see how well they recover. The outcome of this study could help determine the best surgical option for people suffering from this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with single trigger finger that failed conservative treatment
- • Patients with single trigger finger that had recurrence of symptoms after conservative treatment
- Exclusion Criteria:
- • Patients with limited range of movement before appearance of triggering
- • Patients with osteoarthritis / rheumatoid arthritis
- • Patients that had a second procedure at the same time of trigger finger release (eg carpal tunnel release).
About Eleni Karagergou
Eleni Karagergou is a dedicated clinical trial sponsor committed to advancing medical research through innovative and rigorous study designs. With a strong background in clinical operations and regulatory affairs, she focuses on facilitating the development of novel therapies that address unmet medical needs. Her expertise encompasses a wide range of therapeutic areas, and she prioritizes collaboration with research institutions and healthcare professionals to ensure the highest standards of safety and efficacy are met in all trials. Eleni is passionate about improving patient outcomes and fostering a culture of ethical research practices within the clinical trial landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Thessaloniki, Greece
Patients applied
Trial Officials
Panagiotis Givissis, Professor
Study Chair
Aristotle University Of Thessaloniki
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported